Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
88.2M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$2.1B
-
Value change
-
+$33.1M
-
Put/Call ratio
-
0.32
-
Number of buys
-
68
-
Number of sells
-
-57
-
Price
-
$23.82
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2022
156 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q4 2022.
Revolution Medicines, Inc. - Common Stock (RVMD) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.2M shares
of 186M outstanding shares and own 47.47% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (8.87M shares), VANGUARD GROUP INC (7.56M shares), BlackRock Inc. (6.58M shares), Bellevue Group AG (4.86M shares), Column Group LLC (4.58M shares), EcoR1 Capital, LLC (4.46M shares), Nextech Invest Ltd. (4.19M shares), Boxer Capital, LLC (3.98M shares), STATE STREET CORP (3.78M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3.68M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.